C1-esterase inhibitor substitution in sepsis
C. Erik Hack(Center for Translational Molecular Medicine), LambertusG. Thijs, HuibertusJ. Voerman, Heinz-Otto Keinecke, Bernd Eisele, AnkeJ.M. Eerenberg, R. J. M. Strack van Schijndel(Van Andel Institute), Aernout C. Ogilvie(The Netherlands Cancer Institute), Ulrich Delvos, JanH. Nuijens
Cited by 69
Related Papers
High-Dose Antithrombin III in Severe Sepsis
|JAMA|2001|1.4k
Optimal Protein and Energy Nutrition Decreases Mortality in Mechanically Ventilated, Critically Ill Patients
|Journal of Parenteral and Enteral Nutrition|2011|421
Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: A randomized study*
|Critical Care Medicine|2006|373
Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit
|Critical Care Medicine|1990|368
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*
|Critical Care Medicine|2006|188